TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 142.00
-1.00 (-0.70%)
Oct 20, 2026, 1:30 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 9.43 billion as of October 20, 2026. It is the 18,312th most valuable company in the world and the 741st biggest in Taiwan. Its market cap has increased by 15.35% in one year.
Market Cap
9.43B
Enterprise Value
8.25B
Revenue
701.63M
Global Rank
Country Rank
#741 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 9.43B, an increase of 589.57%. That is a compound annual growth rate of 14.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 9.43B | -7.66% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumosa Therapeutics | 12.71B |
| AP Biosciences | 11.90B |
| TWi Biotechnology | 9.45B |
| Locus Cell | 8.71B |
| PharmaEngine | 8.25B |
| Tanvex BioPharma | 8.11B |
| Adimmune | 7.76B |
| Acepodia | 7.70B |